Stock BNTX BIONTECH SE
Add to a list
To use this feature you must be a member
Log inSign up

News BioNTech SE Wiener Boerse

Equities

BNTX

US09075V1026

End-of-day quote Wiener Boerse
Other stock markets
 06:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
87.3 EUR -2.29% Intraday chart for BioNTech SE -7.18% -8.57%
Jun. 11 European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading MT
Jun. 10 European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioNTech : ASCO 2024
PU
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading
MT
Indonesia ramps up fight against tuberculosis amid concerns on economic impact
RE
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
RE
BioNTech : ASCO 2024
PU
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
MT
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
AQ
Genmab A/S and Biontech SE Announce Initial Data from the Phase 2 Gct1046-04 Trial (NCT05117242) Evaluating Acasunlimab
CI
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
GL
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower
MT
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP
AQ
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
AQ
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 17 May 2024)
PU
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 1 June 2022)
PU
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 22 June 2021)
PU
BioNTech : Publication of the resolutions and system for the remuneration of the members of the management Board (resolution of the AGM on 17 May 2024)
PU
BioNTech, CEPI Expand Partnership for mRNA Vaccine Ecosystem in Africa
MT
BioNTech gets $145 mln funding for African vaccine plants
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNTX Stock
  4. BNTX Stock
  5. News BioNTech SE